Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy

Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
Journal of Nuclear Medicine September 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226
Mark C. Markowski
1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Isaacsson Velho
1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;
2Department of Medical Oncology, Hospital Moinhos de Vento, Porto Alegre, Brazil;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario A. Eisenberger
1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin G. Pomper
1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;
3Russel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth J. Pienta
4James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Gorin
4James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmanuel S. Antonarakis
1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel R. Denmeade
1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven P. Rowe
1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;
3Russel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 62 no. 9 1270-1273
DOI 
https://doi.org/10.2967/jnumed.120.259226
PubMed 
33452039

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 24, 2020
  • Accepted for publication January 3, 2021
  • Published online September 2, 2021.

Article Versions

  • previous version (January 15, 2021 - 11:26).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Mark C. Markowski1,
  2. Pedro Isaacsson Velho1,2,
  3. Mario A. Eisenberger1,
  4. Martin G. Pomper1,3,
  5. Kenneth J. Pienta4,
  6. Michael A. Gorin4,
  7. Emmanuel S. Antonarakis1,
  8. Samuel R. Denmeade1 and
  9. Steven P. Rowe1,3
  1. 1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;
  2. 2Department of Medical Oncology, Hospital Moinhos de Vento, Porto Alegre, Brazil;
  3. 3Russel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  4. 4James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
  1. For correspondence or reprints, contact Mark C. Markowski (mmarko12{at}jhmi.edu).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 8 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • [18F]DCFPyL PET/CT for Imaging of Prostate Cancer
    Steven P. Rowe, Andreas Buck, Ralph A. Bundschuh, Constantin Lapa, Sebastian E. Serfling, Thorsten Derlin, Takahiro Higuchi, Michael A. Gorin, Martin G. Pomper, Rudolf A. Werner
    Nuklearmedizin - NuclearMedicine 2022 61 03
  • ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update
    Baris Turkbey, Aytekin Oto, Brian C. Allen, Oguz Akin, Lauren F. Alexander, Mim Ari, Adam T. Froemming, Pat F. Fulgham, Lori Mankowski Gettle, Jodi K. Maranchie, Seth A. Rosenthal, Nicola Schieda, David M. Schuster, Aradhana M. Venkatesan, Mark E. Lockhart
    Journal of the American College of Radiology 2023 20 5
  • Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate Cancer
    Stephan Probst, Anders Bjartell, Aseem Anand, Tayna Skamene, Cristiano Ferrario
    Nuclear Medicine and Molecular Imaging 2022 56 4
  • Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate Cancer
    Hossein Jadvar, Patrick M. Colletti
    PET Clinics 2022 17 3
  • Prognostic Role of PSMA-Targeted Imaging in Metastatic Castration-Resistant Prostate Cancer: An Overview
    Matteo Caracciolo, Angelo Castello, Massimo Castellani, Mirco Bartolomei, Egesta Lopci
    Biomedicines 2024 12 10
  • PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy
    Jorge D. Oldan, Frankis Almaguel, Andrew F. Voter, Alfonso Duran, Andrei Gafita, Martin G. Pomper, Thomas A. Hope, Steven P. Rowe
    The Cancer Journal 2024 30 3
  • Prostate-Specific Membrane Antigen-Ligand Therapy
    Steven P. Rowe, Mohammad S. Sadaghiani, Andrei Gafita, Sara Sheikhbahaei, Martin G. Pomper, Jeffrey Young, Avery Spitz, Rudolf A. Werner, Jorge D. Oldan, Lilja B. Solnes
    Radiologic Clinics of North America 2024 62 1
  • 18F-Labeled Radiotracers for Prostate-specific Membrane Antigen
    Steven P. Rowe, Ali Salavati, Rudolf A. Werner, Kenneth J. Pienta, Michael A. Gorin, Martin G. Pomper, Lilja B. Solnes
    PET Clinics 2022 17 4

Article usage

Article usage: January 2021 to April 2025

AbstractFullPdf
Jan 20211832070
Feb 2021420012
Mar 2021221010
Apr 202115904
May 20219304
Jun 202112607
Jul 202187034
Aug 202189018
Sep 202110978589
Oct 2021475919
Nov 2021308426
Dec 2021405616
Jan 2022448314
Feb 2022404310
Mar 20226727728
Apr 20224819833
May 20222420218
Jun 20222428228
Jul 20221334515
Aug 20221422617
Sep 20221132818
Oct 20221016412
Nov 2022109615
Dec 2022153949
Jan 20232242311
Feb 2023635814
Mar 2023837617
Apr 2023125211
May 2023724911
Jun 20231022512
Jul 2023721913
Aug 20231131726
Sep 20231426015
Oct 2023411114
Nov 20238888
Dec 202314597
Jan 202431777
Feb 2024822613
Mar 2024910035
Apr 202443824
May 2024133012
Jun 2024134013
Jul 2024107025
Aug 2024119026
Sep 202422617
Oct 2024122222
Nov 202472114
Dec 2024113316
Jan 2025152832
Feb 2025187016
Mar 202594840
Apr 2025213630
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (9)
Journal of Nuclear Medicine
Vol. 62, Issue 9
September 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade, Steven P. Rowe
Journal of Nuclear Medicine Sep 2021, 62 (9) 1270-1273; DOI: 10.2967/jnumed.120.259226

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade, Steven P. Rowe
Journal of Nuclear Medicine Sep 2021, 62 (9) 1270-1273; DOI: 10.2967/jnumed.120.259226
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Theranostics

  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
  • 177Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Show more Theranostics

Clinical

  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
  • 177Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Show more Clinical

Similar Articles

Keywords

  • PSMA
  • testosterone
  • early progression
SNMMI

© 2025 SNMMI

Powered by HighWire